Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients
Clinical trial NCT01523431 · COMPLETED
Trial details
- NCT number
- NCT01523431
- Sponsor
- The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-08
- Primary completion
- 2015-11-23
- Enrollment
- 583
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.